search
Back to results

Alveolar Cleft Repair Using Osteoinductive Ceramics (ACROSTIC)

Primary Purpose

Cleft Palate Children, Cleft Alveolar Ridge, Cleft Lip and Palate

Status
Recruiting
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Unilateral alveolar cleft repair
Sponsored by
UMC Utrecht
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cleft Palate Children focused on measuring cleft palate, cleft lip, alveolar cleft, calcium phosphate ceramics, bone graft

Eligibility Criteria

8 Years - 12 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • unilateral alveolar cleft, early secondary alveolar cleft closure

Exclusion Criteria:

  • cleft lip and palate in a syndromic context

Sites / Locations

  • Amsterdam UMCRecruiting
  • UMC GroningenRecruiting
  • Radboud UMCRecruiting
  • UMC UtrechtRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Other

Other

Arm Label

Alveolar cleft repair using autologous bone from the mandibular symphysis

Alveolar cleft repair using a biphasic clacium phosphate putty

Arm Description

Outcomes

Primary Outcome Measures

Bone volume
One year postoperative residual bone volume

Secondary Outcome Measures

Postoperative pain
Postoperative pain on a 1 to 10 scale
Canine eruption
Eruption of the canine (or lateral incisor) adjacent to the alevolar cleft

Full Information

First Posted
April 11, 2022
Last Updated
November 2, 2022
Sponsor
UMC Utrecht
Collaborators
Radboud University Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Academisch Ziekenhuis Groningen
search

1. Study Identification

Unique Protocol Identification Number
NCT05331456
Brief Title
Alveolar Cleft Repair Using Osteoinductive Ceramics
Acronym
ACROSTIC
Official Title
Alveolar Cleft Repair Using Osteoinductive Ceramics in Children With Unilateral Cleft Lip and Palate
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Recruiting
Study Start Date
June 1, 2022 (Actual)
Primary Completion Date
February 1, 2025 (Anticipated)
Study Completion Date
February 1, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
UMC Utrecht
Collaborators
Radboud University Medical Center, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA), Academisch Ziekenhuis Groningen

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In this study, patients with unilateral cleft lip and palate are enrolled in a multicenter stepped wedge randomized trial ithat compares alveolar cleft closure using autologous bone harvested form the mandibular symphysis with an osteoinductive biphasic calcium phosphate putty.
Detailed Description
Rationale: Patients who undergo alveolar cleft grafting have to deal with postoperative pain and comorbidity due to harvesting of autologous bone. Objective: To evaluate if using calcium phosphate based scaffolds for alveolar cleft grafting is as effective as the use of an autologous bone graft. Study design: A 'stepped wedge' randomized controlled trial will be conducted by four centres. Study population: Children between the ages of 8 to 12 years with a unilateral alveolar cleft. Intervention: Study group undergoes alveolar cleft grafting with the use of a calcium phosphate based scaffold, the control group undergoes the same procedure, but with the use of an autologous chin bone graft. Main study parameters/endpoints: Main study outcome is one year postoperative residual bone volume in the reconstructed alveolar cleft. Secondary objectives of importance are postoperative pain and eruption of the tooth adjacent to the cleft through the reconstructed area. Nature and extent of the burden and risks associated with participation, benefit and group relatedness: Patients in the control group will undergo a procedure that is currently seen as the gold standard. Patients in the study group will undergo the exact same risks as the control group, except there is no risk for donor site morbidity and postoperative pain is significantly less. Postoperative clinical and radiological evaluation of both groups is according to current treatment standards.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cleft Palate Children, Cleft Alveolar Ridge, Cleft Lip and Palate
Keywords
cleft palate, cleft lip, alveolar cleft, calcium phosphate ceramics, bone graft

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Stepped wedge cluster randomized trial
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
60 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Alveolar cleft repair using autologous bone from the mandibular symphysis
Arm Type
Other
Arm Title
Alveolar cleft repair using a biphasic clacium phosphate putty
Arm Type
Other
Intervention Type
Device
Intervention Name(s)
Unilateral alveolar cleft repair
Intervention Description
Early secondary alveolar cleft repair is performed in children with a unilateral alveolar cleft using eirther autologous bone or a calcium phosphate based putty
Primary Outcome Measure Information:
Title
Bone volume
Description
One year postoperative residual bone volume
Time Frame
1 year postoperatively
Secondary Outcome Measure Information:
Title
Postoperative pain
Description
Postoperative pain on a 1 to 10 scale
Time Frame
Day 1 to 7 postoperatively
Title
Canine eruption
Description
Eruption of the canine (or lateral incisor) adjacent to the alevolar cleft
Time Frame
1 year postoperatively

10. Eligibility

Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
12 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: unilateral alveolar cleft, early secondary alveolar cleft closure Exclusion Criteria: cleft lip and palate in a syndromic context
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Nard Janssen, MD, DDS, PhD
Phone
0887574560
Ext
+31
Email
n.g.janssen-2@umcutrecht.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Nard Janssen, MD, DDS, PhD
Organizational Affiliation
UMC Utrecht
Official's Role
Principal Investigator
Facility Information:
Facility Name
Amsterdam UMC
City
Amsterdam
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Jitske Nolte, MD, DDS, PhD
Facility Name
UMC Groningen
City
Groningen
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Johan Jansma, MD, DDS, PhD
First Name & Middle Initial & Last Name & Degree
Rutger Schepers, MD, DDS, PhD
Facility Name
Radboud UMC
City
Nijmegen
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marloes Nienhuijs, MD, DDS, PhD
Facility Name
UMC Utrecht
City
Utrecht
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Nard Janssen, MD, DDS, PhD
Phone
+31887574560
Email
n.g.janssen-2@umcutrecht.nl

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Alveolar Cleft Repair Using Osteoinductive Ceramics

We'll reach out to this number within 24 hrs